Congratulations @Philippe_Bedard on the ESMO-TAT Honorary Award 2025 @CDNCancerTrials
MDICT 2024 recommendations for neoadjuvant early clinical trials now published. Led by ESMO-TAT chairs @lillian_siu @ElenaGarralda @AnastasiosStat2 and MDICT’24 team supported by @myESMO
sciencedirect.com/science/ar…
Dr Helen Mackay presenting our ongoing trial IND.240 #ASCO23 @JEDancey @CDNCancerTrials @CancerResearch @DrPOGaudreau for patients with high grade serous ovarian cancer
(2/3) I also invite you to visit our CCTG IND trial posters at ASCO, including IND.240 (Dr. Helen MacKay):
Time: Jun/5/2023, 1:15 PM CDT Hall A
meetings.asco.org/abstracts-…
@INDProgramCCTG @CDNCancerTrials
#immunotherapy #ovariancancer
Dr Quincy Chu concluding his presentation of IND.227, a collaboration of
@istitutotumori
@IFCTlung
@CDNCancerTrials
Replying to @occhio_notizie @LSeymourMD
Great to have worked again with our long-standing collaborators in Naples - un grande piacere aver collaborato nuovamente con NCI Napoli














